Investments & digital assets › F8949.A.M16
F8949.A.M16 · federal · F8949 line A.M16
Meadowlark Biotech (acquired 2025-08-20, sold 2025-11-03; proceeds 1,180.00, basis 1,040.00)
140
engine v3
not yet verified
How this number was built
R-8949-LOT One line per sale: proceeds minus basis plus adjustment. Broker basis is used as reported unless a supplemental statement for the same lot is matched.
Sources (6) — where the inputs came from
Meridian Brokerage 2025 consolidated Form 1099 - CORRECTED (joint)
D31 · page 9 · field M16_description · “Lot M16 description”
read as “Meadowlark Biotech” → Meadowlark Biotech
99%
Meridian Brokerage 2025 consolidated Form 1099 - CORRECTED (joint)
D31 · page 9 · field M16_acquired · “Lot M16 date acquired”
read as “08/20/2025” → 2025-08-20
99%
Meridian Brokerage 2025 consolidated Form 1099 - CORRECTED (joint)
D31 · page 9 · field M16_sold · “Lot M16 date sold”
read as “11/03/2025” → 2025-11-03
99%
Meridian Brokerage 2025 consolidated Form 1099 - CORRECTED (joint)
D31 · page 9 · field M16_proceeds · “Lot M16 proceeds”
read as “1,180.00” → 1,180
99%
Meridian Brokerage 2025 consolidated Form 1099 - CORRECTED (joint)
D31 · page 9 · field M16_basis · “Lot M16 cost basis”
read as “1,040.00” → 1,040
99%
Meridian Brokerage 2025 consolidated Form 1099 - CORRECTED (joint)
D31 · page 9 · field M16_wash · “Lot M16 wash sale loss disallowed”
read as “0.00” → 0
99%
Flows into
History — nothing is overwritten
v1 · 2026-03-04: 140v2 · 2026-03-19: 140v3 · 2026-06-23: 140
Adjust this number
Evidence & discussion
Record how you verified it